HER2-CAR-T (UTC therapeutics)

HER2-CAR-T（优替济生）

Report date: 2024/01/31 14:14:52

Base Information

Drug NameHER2-CAR-T (UTC therapeutics)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionAnti-HER2
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsOvarian NeoplasmsPancreatic NeoplasmsBreast Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesUTC Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesUTC Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsOvarian NeoplasmsPancreatic NeoplasmsBreast Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A